The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance-Reference-Cited by-同舟云学术

The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance

Published:2020-11 Issue: Volume: Page:
ISSN:2319-4170
Container-title:Biomedical Journal
language:en
Short-container-title:Biomedical Journal

Author:

Huang Tzu-Hsin,Yang Shih-Cheng,Tai Wei-Chen,Liang Chih-Ming,Kuo Chung-Mou,Yao Chih-Chien,Wu Cheng-Kun,Kuo Yuan-Hung,Chou Yeh-Pin,Lee Chen-Hsiang,Wu Keng-Liang,Chuah Seng-Kee

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report;Malfertheiner;Gut,2017

2. Strategies for Helicobacter pylori eradication in the year 2020;Pellicano;Saudi J Gastroenterol,2020

3. Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020;Tan;Gastrointest Endosc,2019

4. Risk factors and Incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study;Kumar;Gastroenterology,2020

5. Helicobacter pylori treatment in the era of increasing antibiotic resistance;Graham;Gut,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10-Day versus 14-day bismuth quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomised, open-label, non-inferiority trial;eClinicalMedicine;2024-04

2. Current Perspective on the Treatment of Helicobacter pylori Infection;Tertiary Care - Medical, Psychosocial, and Environmental Aspects;2024-02-28

3. Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori;Expert Review of Anti-infective Therapy;2023-05-12

4. The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial;Infectious Diseases and Therapy;2023-05

5. Multiple amino acid substitutions in penicillin-binding protein-1A confer amoxicillin resistance in refractory Helicobacter pylori infection;Journal of Microbiology, Immunology and Infection;2023-02